Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francis Megerlin

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Health Affairs (Project Hope)|April 6, 2026
'Most Favored Nation' Policies And Value-Based Drug Pricing: A European ViewFrancis Megerlin
Annales Pharmaceutiques Francaises|March 14, 2024
European Health Data Space Act proposal silent on "quality and utility label" of synthetic patient data. Consequences?Francis Megerlin, Erwan Pinilla
Annales Pharmaceutiques Francaises|April 24, 2025
Drug deprescribing policy and incentives in FranceFrancis Megerlin, Gilles Bouvenot, Patrice Queneau
La Revue Du Praticien|June 23, 2025
[Deprescribing to save lives?]Gilles Bouvenot, Francis Megerlin, Patrice Queneau
Health Affairs (Project Hope)|October 9, 2013
Biosimilars and the European experience: implications for the United StatesFrancis Megerlin, Ruth Lopert, Ken Taymor, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Health Affairs (Project Hope)|April 6, 2026
'Most Favored Nation' Policies And Value-Based Drug Pricing: A European ViewFrancis Megerlin
Annales Pharmaceutiques Francaises|March 14, 2024
European Health Data Space Act proposal silent on "quality and utility label" of synthetic patient data. Consequences?Francis Megerlin, Erwan Pinilla
Annales Pharmaceutiques Francaises|April 24, 2025
Drug deprescribing policy and incentives in FranceFrancis Megerlin, Gilles Bouvenot, Patrice Queneau
La Revue Du Praticien|June 23, 2025
[Deprescribing to save lives?]Gilles Bouvenot, Francis Megerlin, Patrice Queneau
Health Affairs (Project Hope)|October 9, 2013
Biosimilars and the European experience: implications for the United StatesFrancis Megerlin, Ruth Lopert, Ken Taymor, et al.
Pageof 1